US Drug Watchdog Launches A Vital Investigation Involving Women Who Suffered Femur Or Thighbone frac

US Drug Watchdog Launches A Vital Investigation Involving Women Who Suffered Femur Or Thighbone fractures While Using The Osteoporosis Drug Fosamax The US Drug Watchdog is launching a vital investigation involving the osteoporosis drug called Fosamax, and women who may have suffered out of the blue fractures to their femur, or thigh bone. According to the FDA, "typically these fractures occurred after using Fosamax for five years, or more." The US Drug Watchdog says, "In the instance of Fosamax, we are talking about women, whose leg simply broke. They did not fall, they did n
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations